Table 1 Biochemical and clinical characteristics of compared groups.
Patients | Control group | P | |
|---|---|---|---|
Mean age (SD) | 61.5 (6.6) | 61.7 (5.9) | 0.59 |
ALT U/l median (IQR) | 28 (21–29.5) | 29 (25.3–32.5) | 0.8 |
AST U/l median (IQR) | 23 (19–28) | 20 (17.8–24) | 0.22 |
Creatinine mg/dl median (IQR) | 1 (0.9–1) | 1 (0.9–1) | 0.67 |
hsCRP mg/dl median (IQR) | 1.8 (1–3.2) | 1.5 (0.6–2.7) | 0.51 |
AHI median (IQR) | 24 (15.3–47.2) | 2.9 (1.1–3.8) | <0.00 |
ODI median (IQR) | 23 (12.9–47.3) | 3 (0.8–4.6) | <0.00 |
Glucose mg/dL median (IQR) | 110 (101–121) | 99 (99–113) | 0.02 |
LH mIU/ml median (IQR) | 5 (3.4–6.8) | 5.3 (3.8–6.2) | 0.87 |
Nesfatin nmol/l median (IQR) | 5 (4.6–6.4) | 2.9 (4.5–12.7) | 0.24 |
Testosterone nmol/l median (IQR) | 12.3 (9.1–16.1) | 13.4 (12.1–17.5) | 0.08 |
BMI median kg/m2 (IQR) | 30.15 (28.7–34.8) | 27.5 (24.7–30.4) | <0.00 |
